This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cornell University. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Ramee Lee: Innovator in Neurotrophin Research
Introduction
Ramee Lee is a distinguished inventor based in New York, NY (US). He has made significant contributions to the field of neurotrophin research, holding a total of 2 patents. His work focuses on methods for inhibiting apoptosis, which is crucial for various therapeutic applications.
Latest Patents
Ramee Lee's latest patents include a method for inhibiting apoptosis through the p75 neurotrophin receptor. This invention provides an isolated protein comprising a pro-domain of a proneurotrophin, along with methods for producing the protein and pharmaceutical compositions containing it. Additionally, the invention offers a nucleic acid molecule that encodes the protein and a vector containing this nucleic acid. The patent also details methods for cleaving a proneurotrophin protein to a mature neurotrophin and inducing apoptosis in cells expressing p75 surface receptors. Another significant patent is for a high-affinity ligand for the p75 neurotrophin receptor, which shares similar features and applications.
Career Highlights
Ramee Lee is affiliated with Cornell University, where he continues to advance his research in neurotrophins. His innovative work has the potential to impact various medical fields, particularly in understanding and treating conditions associated with apoptosis.
Collaborations
Some of Ramee Lee's notable coworkers include Kenneth K Teng and Pouneh Kermani, who contribute to his research endeavors.
Conclusion
Ramee Lee's contributions to neurotrophin research through his patents highlight his role as an influential inventor in the field. His work not only advances scientific understanding but also opens new avenues for therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
